| Appearance | White to faint yellow lyophilized powder | |||||
| Solubility (Solvent) | Water | |||||
| Solubility (Conc) | 4.90 – 5.10 mg/mL | |||||
| Solubility (Turbidity) | Clear to Hazy | |||||
| Solubility (Color) | Colorless to Faint Yellow | |||||
| Protein Content (Method) | Lowry-TCA | |||||
| Prot. Content (% Protein) | ≤ 3.00 % | |||||
| Potency (Sample EU/mg) |  ≥ 500000 EU/mg | |||||
Active Pharmaceutical Ingredients
Lipopolysaccharides (LPS)
Lipopolysaccharides from Escherichia coli O127:B8
| Biological Source | Lipopolysaccharides from Escherichia coli O127:B8 | |||||||||
| Purified By | Phenol Extraction | |||||||||
| Storage Temperature | Cooler/Refrigerated | |||||||||
| Unit | Price |
| 10 mg | 12500 |
| 25 mg | 24000 |
| 100 mg | 44500 |
| Note | •Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia. |
|---|
